CL2008003758A1 - Compuestos derivados de 1(2)h-tetrazol-5-il-fenil-oxazolidinonas, procedimiento de preparacion, composicion farmaceutica, util para el tratamiento de infecciones bacterianas. - Google Patents

Compuestos derivados de 1(2)h-tetrazol-5-il-fenil-oxazolidinonas, procedimiento de preparacion, composicion farmaceutica, util para el tratamiento de infecciones bacterianas.

Info

Publication number
CL2008003758A1
CL2008003758A1 CL2008003758A CL2008003758A CL2008003758A1 CL 2008003758 A1 CL2008003758 A1 CL 2008003758A1 CL 2008003758 A CL2008003758 A CL 2008003758A CL 2008003758 A CL2008003758 A CL 2008003758A CL 2008003758 A1 CL2008003758 A1 CL 2008003758A1
Authority
CL
Chile
Prior art keywords
oxazolidinones
tetrazol
phenyl
useful
treatment
Prior art date
Application number
CL2008003758A
Other languages
English (en)
Inventor
Guglietta Antonio
Cano Montserrat
Aplomer Albert
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of CL2008003758A1 publication Critical patent/CL2008003758A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Compuestos derivados de 1(2)h-tetrazol-5-il-fenil-oxazolidinonas, procedimiento de preparación, composición farmacéutica, útil para el tratamiento de infecciones bacterianas.
CL2008003758A 2007-12-17 2008-12-17 Compuestos derivados de 1(2)h-tetrazol-5-il-fenil-oxazolidinonas, procedimiento de preparacion, composicion farmaceutica, util para el tratamiento de infecciones bacterianas. CL2008003758A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07150077A EP2072514A1 (en) 2007-12-17 2007-12-17 1(2)H-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents

Publications (1)

Publication Number Publication Date
CL2008003758A1 true CL2008003758A1 (es) 2009-08-07

Family

ID=39247140

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008003758A CL2008003758A1 (es) 2007-12-17 2008-12-17 Compuestos derivados de 1(2)h-tetrazol-5-il-fenil-oxazolidinonas, procedimiento de preparacion, composicion farmaceutica, util para el tratamiento de infecciones bacterianas.

Country Status (6)

Country Link
EP (1) EP2072514A1 (es)
AR (1) AR069716A1 (es)
CL (1) CL2008003758A1 (es)
TW (1) TW200936580A (es)
UY (1) UY31541A1 (es)
WO (1) WO2009077485A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101128029B1 (ko) 2010-03-08 2012-03-29 주식회사 레고켐 바이오사이언스 (ｒ)-3-(3-플루오로-4-(1-메틸-5,6-다이하이드로-1,2,4-트리아진-4(1ｈ)-일)페닐)-5-(치환된 메틸)옥사졸리딘-2-온 유도체의 제조방법
WO2012121424A1 (ko) * 2011-03-04 2012-09-13 (주)레고켐바이오사이언스 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100441334B1 (ko) * 1995-02-03 2004-10-20 파마시아 앤드 업존 캄파니 헤테로-방향족고리치환된페닐옥사졸리딘온항균제
CA2294293A1 (en) * 1997-07-11 1999-01-21 Pharmacia & Upjohn Company Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents
CA2411859A1 (en) * 2000-06-05 2001-12-13 Jae-Gul Lee Novel oxazolidinone derivatives and a process for the preparation thereof
WO2006038100A1 (en) * 2004-10-08 2006-04-13 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials

Also Published As

Publication number Publication date
TW200936580A (en) 2009-09-01
EP2072514A1 (en) 2009-06-24
WO2009077485A2 (en) 2009-06-25
WO2009077485A3 (en) 2009-08-13
AR069716A1 (es) 2010-02-10
UY31541A1 (es) 2009-07-17

Similar Documents

Publication Publication Date Title
DK2164331T3 (da) Borholdige små molekyler
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
CL2009000426A1 (es) Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
EA201170772A1 (ru) Органические соединения
MY153915A (en) Organic compounds
EP1962838A4 (en) Farnesoid X RECEPTOR AGONISTS
TW200734344A (en) Antibacterial agents
SG178952A1 (en) Chemical compounds
CL2007003758A1 (es) Compuestos derivados de aminopirimidina, inhibidores de plk1; composicion farmaceutica, util para el tratamiento de cancer.
CL2009001993A1 (es) Compuestos derivados de 6-oxo-4-fenilamino-1,6-dihidropiridina-3-amida, inhibidores de mek; proceso de preparacion de estos, utiles en el tratamiento de un trastorno hiperproliferativo o una condicion inflamatoria. (divisional de la solicitud cl 1168-06)
WO2008051942A3 (en) Farnesoid x receptor agonists
JO2778B1 (en) Certain vehicles, installations and methods
CL2007002890A1 (es) Compuestos derivados de 2-piridincarboxamida, activador de glucosinasa; composicion farmaceutica; y uso del compuesto para el tratamiento de diabetes o la obesidad.
WO2006120563A3 (en) Antibacterial agents
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
CL2007000595A1 (es) Compuestos derivados de piperidina; composicion farmaceutica y uso para el tratamiento y/o profilaxis de enfermedades seleccionadas entre hipertension, insuficiencia cardiaca congestiva e insuficiencia renal entre otras.
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
CL2008000629A1 (es) Compuestos macrociclicos derivados de 6-aril-4-mercapto-[1.3.5]triazina/[1.3]pirimidin-2-amina; composicion farmaceutica, utiles en el tratamiento del cancer.
CL2007001542A1 (es) Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.
CL2008003231A1 (es) Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura.
ATE539082T1 (de) Oxazinylisoflavonoidverbindungen, medikamente und anwendungen
CL2007001747A1 (es) Compuestos derivados de aril y heteroaril-etil-acilguanidina; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento y prevencion de la hipertension, insuficiencia cardiaca y afecciones renales entre otras.
EA200901059A1 (ru) Макролиды на основе эритромицина
BRPI0811557A2 (pt) composto, composição farmacêutica, método de tratamento ou profilaxia de uma condição inflamatória.